Skip to content
PICO Portalanswers from OpenAlex

E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis

PaperCitations, authors & open-access status

E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis is a paper indexed in PICO Portal from OpenAlex.

How many citations does E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis have?

PICO Portalcitation count

E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis has 138 citations in the OpenAlex counts PICO Portal stores.

When was E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis published?

PICO Portalyear

E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis has 2014 year in the PICO Portal index.

What is the open-access status of E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis?

PICO Portaloa status

E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis has bronze oa status in the PICO Portal index.

What is the DOI of E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis?

PICO Portaldoi

The DOI for E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis is on the source record.

What is the PMID of E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis?

PICO Portalpmid

The PMID for E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis is on the source record.

What is the OpenAlex record for E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis?

PICO Portalopenalex

The OpenAlex for E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial